Drug Type Recombinant polypeptide |
Synonyms |
Target |
Mechanism GLP-2R modulators(Glucagon-like peptide 2 receptor modulators) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Short Bowel Syndrome | Phase 3 | IL | 16 Oct 2021 |